News & Articles

Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate

Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer

Commercially available research kits extend access to Breath Biopsy technology for discovery of VOC biomarkers in early disease detection and precision medicine

To be in with a chance of winning a $500/£400/450€ Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your lab in 2017

Agilent Measurement Suite to provide researchers with greater experimental freedom

Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute

Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix

Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease

Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research

Which new product, instrument or consumable has made the most difference to your lab? Nominate now for a chance to win a $500 Amazon voucher

Comprehensive immune profiling & monitoring

Study demonstrates that the test can add prognostic information on overall survival

Mathematical models are used to analyse lymph node morphology and predict risk of cancer spread

Watch our exclusive interviews from industry experts at the Neuroscience 2017 conference

From cancer cells to ocean microbes to Zika virus: Read the interviews that made the most impact in 2017

Discover a new rapid, efficient and reproducible solution for a traditionally complicated method: released N-glycan profiling.

Discover the latest releases, the hottest topics and the stand-out products of the 47th annual society for neuroscience meeting

New biomarker evaluates the biologic activity of blockbuster breast cancer drug Ibrance

Trial will analyze breath biomarkers to improve understanding of the treatment effects of a novel GSK pipeline drug candidate for COPD